Analytical Data
-
Gene name
bp26
- Application
-
Alternative Names
bp26；26 kDa periplasmic immunogenic Protein
-
Species
E.coli
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0A3U8
-
Expression Region
29-250aa
-
AA Sequence
QENQMTTQPARIAVTGEGMMTASPDMAILNLSVLRQAKTAREAMTANNEAMTKVLDAMKKAGIEDRDLQTGGINIQPIYVYPDDKNNLKEPTITGYSVSTSLTVRVRELANVGKILDESVTLGVNQGGDLNLVNDNPSAVINEARKRAVANAIAKAKTLADAAGVGLGRVVEISELSRPPMPMPIARGQFRTMLAAAPDNSVPIAAGENSYNVSVNVVFEIK
-
Molecular Weight
31.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BP26 is a recombinant protein derived from the African swine fever virus (ASFV), which is responsible for a highly contagious and devastating disease in domestic and wild pigs. The increasing incidence of ASF outbreaks globally has raised significant concerns for the swine industry, leading to substantial economic losses and impacting food security. BP26 serves as a potential candidate for vaccine development and diagnostic tools due to its immunogenic properties and its role in viral pathogenesis. Research into BP26 focuses on understanding its structure-function relationship, immune response elicitation, and its potential to induce protective immunity in pigs. Studies have shown that recombinant BP26 can generate specific antibodies that may aid in the identification of infected animals, thus contributing to more effective disease management strategies. The exploration of BP26 not only enhances our understanding of ASFV biology but also provides insights into the development of effective vaccines and diagnostics that could mitigate the impact of this viral threat on the global swine population. As the threat of ASF continues to loom large, advancing the knowledge and application of BP26 is crucial for safeguarding the swine industry and securing food resources worldwide.
